MMP14 and neoplasm: These results are in agreement with recent findings, which indicate a poor 5-year survival rate in patients with increased MMP14 expression regardless of HPV status and make it a potential target since its selective inhibition blocked tumour growth, invasion and angiogenesis [34, 35].